var data={"name":"Hemostasis and thrombosis","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Acquired thrombophilia","type":"SUBSECTION","items":[{"name":"Clinical manifestations and diagnosis of paroxysmal nocturnal hemoglobinuria","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-paroxysmal-nocturnal-hemoglobinuria"},{"name":"Clinical manifestations of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-of-antiphospholipid-syndrome"},{"name":"Diagnosis of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-of-antiphospholipid-syndrome"},{"name":"Drug-induced thrombosis in patients with malignancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=drug-induced-thrombosis-in-patients-with-malignancy"},{"name":"Overview of homocysteine","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-homocysteine"},{"name":"Pathogenesis of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-antiphospholipid-syndrome"},{"name":"Pathogenesis of the hypercoagulable state associated with malignancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-the-hypercoagulable-state-associated-with-malignancy"},{"name":"Primary (spontaneous) upper extremity deep vein thrombosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-spontaneous-upper-extremity-deep-vein-thrombosis"},{"name":"Renal vein thrombosis and hypercoagulable state in nephrotic syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=renal-vein-thrombosis-and-hypercoagulable-state-in-nephrotic-syndrome"},{"name":"Risk and prevention of venous thromboembolism in adults with cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=risk-and-prevention-of-venous-thromboembolism-in-adults-with-cancer"},{"name":"Thrombotic complications following treatment of multiple myeloma with immunomodulatory drugs (thalidomide, lenalidomide, and pomalidomide)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=thrombotic-complications-following-treatment-of-multiple-myeloma-with-immunomodulatory-drugs-thalidomide-lenalidomide-and-pomalidomide"},{"name":"Treatment and prognosis of paroxysmal nocturnal hemoglobinuria","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-paroxysmal-nocturnal-hemoglobinuria"},{"name":"Treatment of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-antiphospholipid-syndrome"},{"name":"Treatment of venous thromboembolism in patients with malignancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-venous-thromboembolism-in-patients-with-malignancy"}]},{"name":"Anticoagulation","type":"SUBSECTION","items":[{"name":"Anticoagulant and antiplatelet therapy in patients with an unruptured intracranial aneurysm","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=anticoagulant-and-antiplatelet-therapy-in-patients-with-an-unruptured-intracranial-aneurysm"},{"name":"Antithrombotic therapy in patients with infective endocarditis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antithrombotic-therapy-in-patients-with-infective-endocarditis"},{"name":"Biology of warfarin and modulators of INR control","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=biology-of-warfarin-and-modulators-of-inr-control"},{"name":"Chronic anticoagulation after acute coronary syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chronic-anticoagulation-after-acute-coronary-syndromes"},{"name":"Clinical presentation and diagnosis of heparin-induced thrombocytopenia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-presentation-and-diagnosis-of-heparin-induced-thrombocytopenia"},{"name":"Clinical use of coagulation tests","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-use-of-coagulation-tests"},{"name":"Direct oral anticoagulants and parenteral direct thrombin inhibitors: Dosing and adverse effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=direct-oral-anticoagulants-and-parenteral-direct-thrombin-inhibitors-dosing-and-adverse-effects"},{"name":"Fondaparinux: Dosing and adverse effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=fondaparinux-dosing-and-adverse-effects"},{"name":"Heparin and LMW heparin: Dosing and adverse effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=heparin-and-lmw-heparin-dosing-and-adverse-effects"},{"name":"Low molecular weight heparin for venous thromboembolic disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=low-molecular-weight-heparin-for-venous-thromboembolic-disease"},{"name":"Management of bleeding in patients receiving direct oral anticoagulants","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-bleeding-in-patients-receiving-direct-oral-anticoagulants"},{"name":"Management of heparin-induced thrombocytopenia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-heparin-induced-thrombocytopenia"},{"name":"Management of warfarin-associated bleeding or supratherapeutic INR","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-warfarin-associated-bleeding-or-supratherapeutic-inr"},{"name":"Perioperative management of patients receiving anticoagulants","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=perioperative-management-of-patients-receiving-anticoagulants"},{"name":"Reversal of anticoagulation in warfarin-associated intracerebral hemorrhage","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=reversal-of-anticoagulation-in-warfarin-associated-intracerebral-hemorrhage"},{"name":"Risk of intracerebral bleeding in patients treated with anticoagulants","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=risk-of-intracerebral-bleeding-in-patients-treated-with-anticoagulants"},{"name":"The use of antithrombotic therapy in patients with an acute or prior intracerebral hemorrhage","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-use-of-antithrombotic-therapy-in-patients-with-an-acute-or-prior-intracerebral-hemorrhage"},{"name":"Treatment and prevention of venous thromboembolism in patients with brain tumors","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prevention-of-venous-thromboembolism-in-patients-with-brain-tumors"},{"name":"Use of anticoagulants during pregnancy and postpartum","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-anticoagulants-during-pregnancy-and-postpartum"},{"name":"Warfarin and other VKAs: Dosing and adverse effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=warfarin-and-other-vkas-dosing-and-adverse-effects"}]},{"name":"Antiphospholipid antibody syndrome","type":"SUBSECTION","items":[{"name":"Clinical manifestations of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-of-antiphospholipid-syndrome"},{"name":"Diagnosis of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-of-antiphospholipid-syndrome"},{"name":"Hematologic manifestations of HIV infection: Thrombocytopenia and coagulation abnormalities","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hematologic-manifestations-of-hiv-infection-thrombocytopenia-and-coagulation-abnormalities"},{"name":"Management of antiphospholipid syndrome in pregnant and postpartum women","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-antiphospholipid-syndrome-in-pregnant-and-postpartum-women"},{"name":"Pathogenesis of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-antiphospholipid-syndrome"},{"name":"Treatment of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-antiphospholipid-syndrome"}]},{"name":"Coagulopathy","type":"SUBSECTION","items":[{"name":"Acquired inhibitors of coagulation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acquired-inhibitors-of-coagulation"},{"name":"Approach to the adult patient with a bleeding diathesis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-the-adult-patient-with-a-bleeding-diathesis"},{"name":"Approach to the adult with epistaxis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-the-adult-with-epistaxis"},{"name":"Approach to the adult with unexplained thrombocytopenia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-the-adult-with-unexplained-thrombocytopenia"},{"name":"Biology and normal function of von Willebrand factor","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=biology-and-normal-function-of-von-willebrand-factor"},{"name":"Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults"},{"name":"Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-hereditary-hemorrhagic-telangiectasia-osler-weber-rendu-syndrome"},{"name":"Cryofibrinogenemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cryofibrinogenemia"},{"name":"Disorders of fibrinogen","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=disorders-of-fibrinogen"},{"name":"Hemostatic abnormalities in patients with liver disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hemostatic-abnormalities-in-patients-with-liver-disease"},{"name":"Management of hereditary hemorrhagic telangiectasia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-hereditary-hemorrhagic-telangiectasia"},{"name":"Nonselective NSAIDs: Overview of adverse effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nonselective-nsaids-overview-of-adverse-effects"},{"name":"Psychogenic purpura (Gardner-Diamond syndrome)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=psychogenic-purpura-gardner-diamond-syndrome"},{"name":"Thrombotic and hemorrhagic disorders due to abnormal fibrinolysis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=thrombotic-and-hemorrhagic-disorders-due-to-abnormal-fibrinolysis"}]},{"name":"Hemophilia and von Willebrand disease","type":"SUBSECTION","items":[{"name":"Acquired inhibitors of coagulation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acquired-inhibitors-of-coagulation"},{"name":"Acquired von Willebrand syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acquired-von-willebrand-syndrome"},{"name":"Biology and normal function of factor VIII and factor IX","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=biology-and-normal-function-of-factor-viii-and-factor-ix"},{"name":"Biology and normal function of von Willebrand factor","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=biology-and-normal-function-of-von-willebrand-factor"},{"name":"Chronic complications and age-related comorbidities in people with hemophilia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chronic-complications-and-age-related-comorbidities-in-people-with-hemophilia"},{"name":"Classification and pathophysiology of von Willebrand disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=classification-and-pathophysiology-of-von-willebrand-disease"},{"name":"Clinical manifestations and diagnosis of hemophilia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-hemophilia"},{"name":"Clinical presentation and diagnosis of von Willebrand disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-presentation-and-diagnosis-of-von-willebrand-disease"},{"name":"Factor VIII and factor IX inhibitors in patients with hemophilia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=factor-viii-and-factor-ix-inhibitors-in-patients-with-hemophilia"},{"name":"Factor XI deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=factor-xi-deficiency"},{"name":"Genetics of hemophilia A and B","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=genetics-of-hemophilia-a-and-b"},{"name":"Hemophilia A and B: Routine management including prophylaxis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hemophilia-a-and-b-routine-management-including-prophylaxis"},{"name":"Rare inherited coagulation disorders","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=rare-inherited-coagulation-disorders"},{"name":"Treatment of bleeding and perioperative management in hemophilia A and B","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-bleeding-and-perioperative-management-in-hemophilia-a-and-b"},{"name":"Treatment of von Willebrand disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-von-willebrand-disease"}]},{"name":"Hemostasis","type":"SUBSECTION","items":[{"name":"Biology and normal function of factor VIII and factor IX","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=biology-and-normal-function-of-factor-viii-and-factor-ix"},{"name":"Biology and normal function of von Willebrand factor","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=biology-and-normal-function-of-von-willebrand-factor"},{"name":"Clinical use of coagulation tests","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-use-of-coagulation-tests"},{"name":"Overview of hemostasis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-hemostasis"},{"name":"Preoperative assessment of hemostasis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=preoperative-assessment-of-hemostasis"},{"name":"Recombinant factor VIIa: Clinical uses, dosing, and adverse effects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=recombinant-factor-viia-clinical-uses-dosing-and-adverse-effects"},{"name":"The endothelium: A primer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-endothelium-a-primer"},{"name":"Vitamin K and the synthesis and function of gamma-carboxyglutamic acid","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=vitamin-k-and-the-synthesis-and-function-of-gamma-carboxyglutamic-acid"}]},{"name":"Inherited thrombophilia","type":"SUBSECTION","items":[{"name":"Antithrombin deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antithrombin-deficiency"},{"name":"Factor V Leiden and activated protein C resistance","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=factor-v-leiden-and-activated-protein-c-resistance"},{"name":"Inherited thrombophilias in pregnancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=inherited-thrombophilias-in-pregnancy"},{"name":"Protein C deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=protein-c-deficiency"},{"name":"Protein S deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=protein-s-deficiency"},{"name":"Prothrombin G20210A mutation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prothrombin-g20210a-mutation"},{"name":"Screening for inherited thrombophilia in asymptomatic adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=screening-for-inherited-thrombophilia-in-asymptomatic-adults"}]},{"name":"Thrombotic microangiopathy","type":"SUBSECTION","items":[{"name":"Acquired TTP: Clinical manifestations and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acquired-ttp-clinical-manifestations-and-diagnosis"},{"name":"Acquired TTP: Initial treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acquired-ttp-initial-treatment"},{"name":"Acquired TTP: Management following recovery from an acute episode and during remission","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acquired-ttp-management-following-recovery-from-an-acute-episode-and-during-remission"},{"name":"Acquired TTP: Treatment of refractory or relapsed disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acquired-ttp-treatment-of-refractory-or-relapsed-disease"},{"name":"Approach to the patient with suspected TTP, HUS, or other thrombotic microangiopathy (TMA)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-the-patient-with-suspected-ttp-hus-or-other-thrombotic-microangiopathy-tma"},{"name":"Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults"},{"name":"Cryofibrinogenemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cryofibrinogenemia"},{"name":"Drug-induced thrombotic microangiopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=drug-induced-thrombotic-microangiopathy"},{"name":"Hematologic manifestations of HIV infection: Thrombocytopenia and coagulation abnormalities","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hematologic-manifestations-of-hiv-infection-thrombocytopenia-and-coagulation-abnormalities"},{"name":"Hereditary thrombotic thrombocytopenic purpura (TTP)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hereditary-thrombotic-thrombocytopenic-purpura-ttp"},{"name":"Pathophysiology of acquired TTP and other primary thrombotic microangiopathies (TMAs)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathophysiology-of-acquired-ttp-and-other-primary-thrombotic-microangiopathies-tmas"},{"name":"Recurrent and de novo HUS after renal transplantation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=recurrent-and-de-novo-hus-after-renal-transplantation"}]},{"name":"Venous thrombosis","type":"SUBSECTION","items":[{"name":"Catheter-related upper extremity venous thrombosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=catheter-related-upper-extremity-venous-thrombosis"},{"name":"Clinical presentation and diagnosis of the nonpregnant adult with suspected deep vein thrombosis of the lower extremity","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-presentation-and-diagnosis-of-the-nonpregnant-adult-with-suspected-deep-vein-thrombosis-of-the-lower-extremity"},{"name":"Deep vein thrombosis and pulmonary embolism in pregnancy: Prevention","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=deep-vein-thrombosis-and-pulmonary-embolism-in-pregnancy-prevention"},{"name":"Deep vein thrombosis and pulmonary embolism in pregnancy: Treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=deep-vein-thrombosis-and-pulmonary-embolism-in-pregnancy-treatment"},{"name":"Deep vein thrombosis in pregnancy: Epidemiology, pathogenesis, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=deep-vein-thrombosis-in-pregnancy-epidemiology-pathogenesis-and-diagnosis"},{"name":"Evaluating adult patients with established venous thromboembolism for acquired and inherited risk factors","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluating-adult-patients-with-established-venous-thromboembolism-for-acquired-and-inherited-risk-factors"},{"name":"Overview of homocysteine","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-homocysteine"},{"name":"Overview of the causes of venous thrombosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-causes-of-venous-thrombosis"},{"name":"Overview of the treatment of lower extremity deep vein thrombosis (DVT)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-treatment-of-lower-extremity-deep-vein-thrombosis-dvt"},{"name":"Prevention of venous thromboembolic disease in acutely ill hospitalized medical adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prevention-of-venous-thromboembolic-disease-in-acutely-ill-hospitalized-medical-adults"},{"name":"Prevention of venous thromboembolic disease in surgical patients","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prevention-of-venous-thromboembolic-disease-in-surgical-patients"}]}]}